| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8366918 | Steroids | 2013 | 6 Pages |
Abstract
- We evaluated the validity of a commercial dihydrotestosterone (DHT) immunoassay.
- Immunoassay overestimated DHT concentrations by 79-1000% compared with LC-MS/MS.
- Immunoassay did not detect reductions in DHT following finasteride treatment.
- Cross-reactivity of the DHT immunoassay ranged from 18% to 99% with testosterone (T).
- This immunoassay is invalid for DHT assessment in biological fluids containing T.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Joshua F. Yarrow, Darren T. Beck, Christine F. Conover, Luke A. Beggs, Bruce A. Goldberger, Stephen E. Borst,